Drug companies maintain “astounding” profits

BMJ 2002; 324 doi: 10.1136/bmj.324.7345.1054/b (Published 4 May 2002)
Cite this as: BMJ 2002;324:1054.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Scott Gottlieb
  1. New York

    Pharmaceuticals again ranked as the most profitable sector in the United States, topping the annual Fortune 500 ranking of America's top industries, released this month.

    The pharmaceutical industry topped all three of Fortune magazine's measures of profitability for 2001, making this decade the third in which the industry has been at or near the top in all the magazine's measures of profitability.

    The occasion was seized by critics of the industry as reflecting corporate greed. Frank Clemente, director of Public Citizen's …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL